Chris Tankersley
About Chris Tankersley
Chris Tankersley is the Senior Director of Clinical Science at BeiGene in San Mateo, CA. He holds an MSc in Entomology from the University of Nebraska-Lincoln and a BS in Animal Physiology and Neuroscience from the University of California, San Diego.
Company
Chris Tankersley is currently employed at BeiGene, a biopharmaceutical company specializing in the development of innovative cancer treatments. Chris holds the position of Senior Director, Clinical Science at the company's San Mateo, CA office. BeiGene focuses on biotechnology advancements and the development of novel oncology therapies.
Title
Chris Tankersley serves as the Senior Director, Clinical Science at BeiGene. In this role, Chris is responsible for overseeing clinical science initiatives, including the design and management of clinical trials and research projects aimed at developing new cancer treatments.
Education and Expertise
Chris Tankersley holds an MSc in Entomology from the University of Nebraska-Lincoln, where he studied from 2014 to 2021. Additionally, he earned a BS in Animal Physiology and Neuroscience from the University of California, San Diego, completing his studies there from 1991 to 1995. His educational background provides a strong foundation in both entomology and the physiological and neurological sciences of animals.
Background in Entomology
Chris Tankersley has an academic background in entomology, having completed his MSc at the University of Nebraska-Lincoln. His studies in this field have equipped him with a deep understanding of insect biology and ecology, which complements his expertise in clinical sciences.
Experience at BeiGene
Chris Tankersley has been part of the BeiGene team since June 2019. In his role as Senior Director, Clinical Science, he contributes to the company's mission of developing life-saving treatments for cancer. His expertise is utilized in the planning and execution of clinical research to advance oncology therapies.